Cargando…
Visual acuity outcome of stable proliferative diabetic retinopathy following initial complete panretinal photocoagulation
BACKGROUND: Recent clinical trials on proliferative diabetic retinopathy (PDR) show that presenting visual acuity can be stabilised with panretinal photocoagulation (PRP) within 2 years despite the need for supplementary PRP or anti-vascular endothelial growth factor therapy for concomitant diabetic...
Autores principales: | Fu, Dun Jack, Thottarath, Sridevi, Faes, Livia, Balaskas, Konstantinos, Keane, Pearse A, Sim, Dawn, Sivaprasad, Sobha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528610/ http://dx.doi.org/10.1136/bmjophth-2022-001068 |
Ejemplares similares
-
Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
por: Nicholson, Luke, et al.
Publicado: (2018) -
A Proposed Classification of Intraretinal Microvascular Abnormalities in Diabetic Retinopathy Following Panretinal Photocoagulation
por: Shimouchi, Akito, et al.
Publicado: (2020) -
Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
por: Lopez-Lopez, F., et al.
Publicado: (2012) -
Electroretinogram Changes Following Sequential Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
por: Khojasteh, Hassan, et al.
Publicado: (2020) -
Efficacy of conbercept combined with panretinal photocoagulation in the treatment of proliferative diabetic retinopathy
por: He, Feng, et al.
Publicado: (2020)